Primary Endpoint Analysis of the Phase 2 DESTINATION-MRL Trial for Patients With Intermediate-Risk Prostate Cancer

Authors:

Abstract
No abstract available
Funding Information
  • Cancer Research UK (A28724)
  • Cancer Research UK (RRCOER-Jun24/100006)
  • Cancer Research UK (C33589/A28284)
  • Royal Marsden NHS Foundation Trust
  • National Institute for Health and Care Research
  • Institute of Cancer Research
  • Elekta

This publication has 36 references indexed in Scilit: